GOULD STEPHEN E (Chief Scientific Officer) sold 12.5% of their position (4.08K shares) of ATRECA, INC. on the open market
Open‑market sale worth $3.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/4/2023ACC: 0001209191-23-044683
Officer· Chief Scientific Officer
Since Jun 2022
-4.08K
Net shares
Net seller
$3.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.08K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−4.08K
Price / share
$0.95
Trade value
$3.88K
% of position
12.5%
8/2/2023
32.50K→28.42K
Total
Net shares
−4.08K
Net value
-$3.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/2/2023 | S · Sale | −4.08K | $0.95 | $3.88K | 12.5% | 32.50K | 28.42K |
| Total | −4.08K | -$3.88K | ||||||
Derivative Transactions0
No derivative transactions reported